Multiple cytokines can synergize t o stimulate the in vitro proliferation and exclusive myeloid differentiation of multipotent bone marrow progenitor cells. The ligand for ckit (stem cell factor [SCFI) plays a key role in stimulating myeloid and erythroid cell production of primitive hematopoietic progenitors. SCF in combination with interleukin-7 (IL-7) can also stimulate the combined myeloid and B-cell differentiation of uncommitted hematopoietic progenitor cells as well as the growth of early B-cell progenitor cells, although the involvement of c-kit in early B lymphopoiesis remains controversial. In the present study, the flt3-ligand (FL), which, in combination with other cytokines, has overlapping activities with SCF on myeloid cell production from uncommitted progenitors, was investigated for its ability t o induce selective stroma-independent B-cell commitment from uncommitted Lin-Sca-l+ bone marrow progenitor cells. IL-7 alone did not induce any clonal growth and FL alone gave rise t o a few clusters (<50 cells) but no colonies b 5 0 cells), whereas the combined stimulation with FL and IL-7 resulted in clonal growth of 10% of Lin-Sca-l' bone marrow cells. After 12 days of incubation of Lin-Sca-l+ cells in FL + IL-7, an almost 400-fold increase in cell production was observed. Phenotyping showed that greater than 99% of the cells produced were of the B-cell lineage, in that they Studies of interleukin-7 (IL-7) or IL-7 receptor (IL-7R)-deficient mice have clearly shown that normal and efficient B-cell development is dependent on IL-7, although the finding of some mature B cells in these mice suggests that B-cell development (to a limited extent) can occur in the absence of IL-7.'*." Whereas pre-B cells can proliferate in vitro in response to IL-7 the proliferation and differentiation of pro-B cells have been suggested to require interaction with stroma cells as well as IL-7.J.'.16"R Furthermore, due to the low frequency and impurity of pro-B cells in bone mar- Laboratory, Hipple Cancer Research Center, Dayton, OH; and Immunex Research and Development Corp, Seattle, WA. Submitted Jumary 25, 1996; accepted 
myeloid and erythroid cell production of primitive hematopoietic progenitors. SCF in combination with interleukin-7 (IL-7) can also stimulate the combined myeloid and B-cell differentiation of uncommitted hematopoietic progenitor cells as well as the growth of early B-cell progenitor cells, although the involvement of c-kit in early B lymphopoiesis remains controversial. In the present study, the flt3-ligand (FL), which, in combination with other cytokines, has overlapping activities with SCF on myeloid cell production from uncommitted progenitors, was investigated for its ability t o induce selective stroma-independent B-cell commitment from uncommitted Lin-Sca-l+ bone marrow progenitor cells. IL-7 alone did not induce any clonal growth and FL alone gave rise t o a few clusters (<50 cells) but no colonies b 5 0 cells), whereas the combined stimulation with FL and IL-7 resulted in clonal growth of 10% of Lin-Sca-l' bone marrow cells. After 12 days of incubation of Lin-Sca-l+ cells in FL + IL-7, an almost 400-fold increase in cell production was observed. Phenotyping showed that greater than 99% of the cells produced were of the B-cell lineage, in that they OSTNATALLY, PRIMARY B-cell genesis in mouse occurs from hematopoietic stem cells residing in the bone marrow and is regulated by interaction with stromal cells and stroma-derived cytokines."' Progenitor B cells (pro-B cells) are the earliest cells committed to the B-cell lineage.',3,4.h These cells have their Ig gene in germline configuration and differentiate through distinct stages into pre-B cells that express high levels of B220 and cytoplasmic pheavy chain (~p).~,'.* Further differentiation occurs through Ig light chain gene rearrangement and synthesis and subsequent expression of IgM at the cell surface (sI~M).~.~.'"' Studies of interleukin-7 (IL-7) or IL-7 receptor (IL-7R)-deficient mice have clearly shown that normal and efficient B-cell development is dependent on IL-7, although the finding of some mature B cells in these mice suggests that B-cell development (to a limited extent) can occur in the absence of IL-7.'*." Whereas pre-B cells can proliferate in vitro in response to IL-7 the proliferation and differentiation of pro-B cells have been suggested to require interaction with stroma cells as well as IL-7.J.'.16"R Furthermore, due to the low frequency and impurity of pro-B cells in bone mar-expressed B220, but not cell surface markers specific for myeloid, erythroid, or T-cell lineages. Furthermore, the cells did not express cytoplasmic p-heavy chain (cp) or surface IgM, but were positive for CD24 (heat stable antigen [HSA] ) and CD43 (leukosialin), suggesting that the cells produced were blocked at a late pro-B-cell stage. Interestingly, although all FL + IL-7-responsive Lin-Sea-l+ progenitor cells and the resulting pro-B cells expressed c-kit, FL + IL-7 was much more potent (62-fold) than SCF + IL-7 in stimulating production of cells of the B-cell lineage. In addition, whereas FL + IL-7 selectively stimulated the production of pro-B cells, SCF + IL-7 predominantly stimulated the production of mature granulocytes. Replating studies showed that FL + IL-7-responsive Lin-Sca-l+ progenitors were not committed t o the B-cell lineage, because after 2 days of incubation in FL + IL-7, 80% of the progenitors retained a myeloid potential. As much as 27% of the FL + IL-7-responsive progenitors remained uncommitted after 7 days of incubation, but all had committed to the B-cell lineage after 10 days of incubation in FL + IL-7. These results show that FL much more potently and selectively than SCF synergizes with IL-7 t o enhance B-cell commitment and development from uncommitted progenitor cells. Q 1996 b y The American Society of Hematology.
row populations used for studies on early B-cell development, pro-B-cell cultures initially produce also myeloid cells, and accordingly purified populations of pro-B-cell progenitors can only be obtained through prolonged culture and selection.'.'" c-kit is a tyrosine kinase receptor encoded in the dominant white-spotting (W) locus in mice.*"." Mutations in the W locus result in deficient hematopoietic stem cells, melanocytes, and germ cells, and the mice are anemic." Administration of c-kit blocking antibodies dramatically suppresses erythropoiesis as well as myelopoiesis, whereas B lymphopoiesis is rather enhanced, implying that c-kit and its ligand might not be essential for B lymphopoiesis.'' However, multiple studies have shown that pro-B as well as pre-B cells express c-kit and that the c-kit ligand (also called stem cell factor [SCF] ) can synergize with IL-7 to recruit B-cell progenitors not responsive to IL-7 Other studies have implicated that the combination of SCF and IL-7 cannot support the growth of pro-B-cell progenitor cells despite ckit expression.' This difference might merely reflect the fact that SCF + IL-7 only stimulate the growth of subsets of Bcell progenitor cells.
Lin"Sca-1 + bone marrow cells, although representing only 0. l % of the nucleated cells in murine bone marrow, contain all long-term multilineage reconstituting stem cells capable of supporting long-term myelopoiesis as well as lymphopoiesis in vivo,''.*' In line with its key role in myelopoiesis, SCF has been shown to potently and selectively stimulate the growth and myeloid differentiation of Lin-Sca-l' progenitor cells in combination with the colony-stimulating factors (CSFs) and multiple interleukins.30-3' Recently, SCF in combination with IL-7 has also been shown to stimulate pre-Bcell production from Lin-Sca-l+ progenitor cells. ' which is predominantly expressed in a transmembrane form, appears to have overlapping activities with SCF in that it synergizes with CSFs and other cytokines to stimulate the production of mature myeloid cells from Lin-Sca-l+ progenitor cells.27.79-42 Interestingly, flt3 has been shown to be expressed on pro-B cells,'" and the dominant defect in flt3-deficient mice is a reduction in primitive B-cell progenitor cells.53 Recently, the flt3 ligand (FL) has, in combination with IL-7, been shown to stimulate the growth of B-cell progenitor cells, although less potently than SCF + IL-7.27
In the present study we investigated the ability of FL to stimulate B-cell commitment and development of uncommitted hematopoietic progenitor cells in murine bone marrow. We show here that FL, in combination with IL-7, much more potently and selectively than SCF stimulates the pro-B-cell formation from multipotent Lin-Sca-l+ bone marrow cells.
Because flt3 has been shown to be expressed on pro-B cells43 and FL recently was shown to stimulate the growth of certain B-cell progenitor cells in murine bone marrow,*' we asked whether FL in combination with IL-7 might be able to stimulate the growth and selective B-cell differentiation from uncommitted murine bone marrow progenitor cells.
MATERIALS AND METHODS
Mice. CS7BL/6 mice were obtained from Jackson Laboratories (Bar Harbor, ME) at 6 to 8 weeks of age and kept in microisolater units with individual cage ventilation and filter tops. Food and water was provided ad libitum. Mice at 8 to 14 weeks of age were used as donors for bone marrow cells.
Hematopoietic growth factors. Recombinant human flt3-ligand (FL) was cloned and purified as previously described." Purified recombinant murine IL-3 was from PeproTech Inc (Rocky Hill, NJ). Purified recombinant human granulocyte colony-stimulating factor (G-CSF) and recombinant rat SCF were generously supplied by Dr Ian McNiece (Amgen Corp. Thousand Oaks, CA). Purified recombinant human IL-7 was a gift from Immunex (Seattle, WA). All cytokines were used at predetermined optimal concentrations: 20 ng/mL IL-3, SO ng/mL G-CSF, 50 ng/mL FL, 100 ng/mL IL-7, and 50 ng/ mL SCF, unless otherwise stated.
Isolation of Lin-Scal' bone marrow cells. Lin-bone marrow cells were isolated from femurs and tibia of normal C57BL/6 mice according to a previously described p r o t o~o l .~~~~' Briefly, bone marrow cells were incubated at 4°C for 30 minutes in a cocktail of predetermined optimal concentrations of antibodies against blood cell lineage-specific cell surface markers: RA3-6B2 (B220 antigen), RB6-8C5 (GR-l antigen), M1170 (Mac-l; CDllb), CD5, CD4, CD8 (all from Pharmingen, San Diego, CA), and TER-I 19 (kindly provided by Dr Tatsuo Kina, Kyoto University, Kyoto, Japan). To remove lineage-expressing cells (Lin'), cells were incubated with sheep antirat IgG-conjugated immunomagnetic beads (Dynal, Oslo, Norway) at a ratio of 1:l for 30 minutes at 4°C. The procedure was repeated with the same absolute number of beads and Lin' cells were removed with a magnetic particle concentrator (MP-6; Dynal). The remaining lineage-depleted (Lin-) cells were concentrated and incubated with saturating amounts of either fluorescein isothiocyanate (F1TC)-conjugated anti-Ly6AE (Sca-l) or irrelevant isotypematched control antibodies. After washing and resuspending the cells, Lin-Scal' bone marrow cells were sorted on a Coulter Epics Elite cell sorter (Coulter Electronics, Hialeah, FL). The final recovery of Lin-Scal' cells was 0.05% to 0.1% of the unfractionated bone marrow. In some experiments, cells were also stained with phycoerythrin (PE)-conjugated monoclonal antibody (MoAb) against c-kit (Pharmingen) or a PE-conjugated isotype-matched control antibody (Pharmingen) simultaneously with Sca-l and Lin-Scal+c-kit+ and Lin-Sca-l'c-kit-cells were sorted. In agreement with others, approximately 40% to 50% of the Sca-l' cells expressed cSingle-cell proliferation assay. Lin-Sca-l' cells were seeded in 60-well microtiter plates (Nunc, Kamstrup, Denmark) at a concentration of 1 cell per well in 20 pL Iscove's modified Dulbecco's medium (IMDM; BioWhittaker, Walkersville, MD) supplemented with 20% fetal calf serum (FCS; BioWhittaker), antibiotics, and L-glutamine (complete IMDM). Wells were scored for colony growth (>50 cells) and clusters (IO to SO cells) after 12 to 14 days of incubation at 37°C and 5% CO2 in air. In some experiments, individual colonies were sampled, transferred to slides by a cytospin centrifuge, and examined morphologically after Giemsa staining or phenotyped as described below.
Immunophenotyping by j o w cytometry. Lin-Scal+ cells were plated in complete IMDM or serum-deprived medium (Xvivol5 Replating of FL + IL-7-responsive Lin-Sca-l' cells. The potential of Lin-Sca-l ' cells responding to FL + IL-7 to differentiate into myeloid cells was determined by seeding 300 cells at a density of 1 cell per well in 10 pL complete IMDM with FL (SO ng/mL) and IL-7 (SO ng/mL) on day 0. Wells containing 2 or more viable cells after 48 hours were scored as responsive to FL + IL-7. No viable cells were observed in cultures incubated for 48 hours in medium alone (data not shown). After 2, 4, 7, and 10 days, responsive clones were identified and 10 pL of complete IMDM containing a potent myeloid stimulus (SCF, G-CSF, and IL-3) was added. Clones were examined after an additional 12 days of incubation for the development of granulocyte (G)-and macrophage (M)-containing colonies as determined by microscopic evaluation of Giemsastained cytospin-preparations of individual clones.
Statistical analysis. Levels of significance for comparisons between groups were determined using the Student's t-test. 
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RESULTS
FL and
20 (3) 29 (3) Lin Sca-l ' cells were isolated as described in the Materials and Methods. In each experiment, 300 Lin Sca-1. cells were seeded at a density of 1 cell per well in 20 pL of complete IMDM (FCS-containing) supplemented with purified recombinant human IL-7 and FL at predetermined optimal concentrations (50 nglmL FL and 100 nglmL IL-7).
Cultures were grown for 10 to 12 days at 37°C and 5% CO, in air.
Clusters (10 to 50 cells) and colonies (>50 cells) were scored with an inverted microscope. Results represent mean (SEM) of three independent experiments.
effects of FL and IL-7. Lin Sca-l cells were cultured at a density of I cell per well in complete IMDM ( Table l ) . Of 300 cells plated. FL (S0 ng/mL) alone stimulated the formation of 7 ? l clusters and no colonies. in agreement with previous studies." Also in agreement with previous reports,3s IL-7 ( I 00 ng/mL) was unable to stimulate clonal growth; in fact. no cells could be observed after 12 days of incubation. However. when IL-7 was combined with FL, a synergistic increase in the number of clusters and colonies formed was observed. resulting in the formation of 9 clusters and 20 colonies ( Table l ) . Recombinant human FL at S0 ng/mL results in optimal myeloid colony formation of Lin"Sca-I' progenitor cells when combined with G-CSF or 1L-3 (Jacobsen et al. unpublished observation). Similarly, 50 ng/ mL of FL optimally synergized with IL-7 (100 ng/mL). A concentration of 100 ng/mL of IL-7 resulted in maximal synergy with FL (Fig l) .
We next asked whether simultaneous stimulation with FL and 1L-7 was required to optimally recruit Lin-Sea-I' progenitor cells or whether it was possible that FL might initiate proliferation and IL-7 act to promote growth and differentiation at a later stage. When addition of IL-7 was delayed for 24 or 48 hours after stimulation with FL, the synergy between the two factors was abrogated, suggesting that simultaneous stimulation of undifferentiated progenitor cells through both flt3 and IL-7R was required for optimal synergy (Fig 2) .
We next examined in more detail the growth characteristics and size of the clones formed in response to FL + IL-7. Whereas all clones formed in response to FL alone contained less than 50 cells on day IO, 80% of the clones formed in response to FL + IL-7 contained more than 50 cells, and 40% were large colonies covering more than 10% of the culture well (Table 2) . However, at this time, no clones covering more than SO% of the well could be identified. !n contrast, after IS and 20 days of incubation, 13% and 20%
of FL + IL-7-stimulated clones had further proliferated to cover more than SO% (some 100%) of the well, respectively (Table 2 ). In addition, a low number of new clones could be identified at this time, suggesting that they had developed from clones containing less than 10 cells at day 10. This was in contrast to FL-stimulated clones that ceased to grow and rather died after 10 to 12 days of incubation (data not Three hundred Lin-Sca-l' cells were seeded at a density of 1 cell per well in 20 pL of complete IMDM supplemented with purified recombinant human IL-7 and FL at predetermined optimal concentrations (50 ng/mL FL and 100 ng/mL IL-7). Cultures were grown for 10, (Fig 4) . FL and IL-7 stimulate the exclusive production of pro-B cells from Lin-Sca-l+ progenitor cells. The cells produced from Lin-Sca-1 + bone marrow cells in response to FL + IL-7 both in bulk liquid culture and from individual clones were homogenous with typical blast cell-like or lymphocytelike characteristics and no mature myeloid cells could be identified (Fig 5) . Cells produced in response to FL + IL-7 were next characterized phenotypically by flow cytometry. All cells expressed high levels of B220 (Fig 6A) , but were negative for sIgM (Fig 6B) , suggesting that the cells might represent undifferentiated B-cell precursors. In addition, all cells were negative for T-lymphoid antigens CD8 and CD4 (Fig 6C and D, respectively) and myeloid and erythroid antigens (Fig 6E) .
Different stages of pro-B-and pre-B-cell differentiation have been established based on the expression of B220 and 1259 sIgM as well as CD43 and CD24?12,13 The FL + IL-7-stimulated B220+ and sIgM-cells coexpressed CD43 and CD24 (Fig 7A) , placing them among fraction B-C pro-B cells according to Hardy et al. 4 Because it has been shown that pro-B cells can express kit,^,'^ we also examined the expression of c-kit and found that almost all FL + IL-7-expanded cells expressed high levels of c-kit at day 12 ( Fig  7B) . In contrast to normal splenocytes (Fig 8A) , but like freshly isolated thymocytes (Fig 8B) , cells produced in response to FL + IL-7 did not express cp (Fig 8C) , further supporting the idea that they are blocked at the pro-B-cell stage.
Comparison between the ability of SCF and FL to synergize with IL-7 in stimulating B-cell growth and differentiation from Lin-Sca-l' progenitor cells, Many pro-B cells we directly compared the ability of FL + IL-7 and SCF + IL-7 to stimulate the growth and differentiation of Lin-Sca-1' progenitors. FL + IL-7 stimulated the production of fourfold more cells than SCF + IL-7 ( P < .001; Fig 9A) . Most cells generated in SCF + IL-7 displayed a typical granulocyte morphology in agreement with that of previous (Fig 9B) , and all cells expressed GR-1 (Fig 9C) , in contrast to cells produced in FL + IL-7 ( Figs 5 and 6 ). Furthermore, because only a small fraction (9.1% f 3.5%) of cells produced in response to SCF + IL-7 expressed B220 (Fig 9D) , FL + IL-7 stimulated production of 62-fold more B220+ cells than did SCF + IL-7 ( P < ,001). Collectively, these data show that FL has a much more potent and selective ability than SCF to stimulate pro-B-cell production from Lin-Sca-l+ progenitors in combination with IL-7.
Lin-Sca-l+ progenitor cells responsive to FL + IL-7 contain multipotenthncomrnitted progenitor cells. Because the FL + IL-7-recruited progenitor cells produced exclusively pro-B cells, they could potentially represent a subpopulation of Lin-Sca-l+ progenitors already committed to Bcell differentiation rather than uncommitted progenitor cells. Thus, we examined whether they also had a myeloid potential. Lin-Sca-l+ cells were plated at 1 cell per well (300 wells per group) in the presence of FL + IL-7. After 2 days, at which time all cells growing in medium alone are dead (Jacobsen et al, unpublished observation), clones containing 2 or more cells were identified and 10 pL of a potent myeloid growth factor combination (SCF + G-CSF + IL-3) was added to these wells only. After an additional 10 days of incubation, the marked wells were scored for the presence of myeloid cells by microscopic evaluation of Giemsa-stained individual clones (Table 3) . Eighty percent of the cells that initially had responded to FL + IL-7 and thus ultimately would become pro-B-cell clones formed myeloid colonies that, in general, were of a high proliferative potential-colonyforming cell (HPP-CFC) type, underscoring their primitive origin. Similar experiments were performed after 4, 7, and 10 days of incubation in FL + IL-7, and the fraction of clones with a myeloid potential was 67%, 27%, and 0%, respectively (Table 3 ). In parallel liquid cultures, the expression of B220 and GR-1 was analyzed on cells incubated in FL + IL-7 (Table 3) . On day 2, all cells were negative for both B220 and GR-1, whereas on day 4, both B220' and B220-cells were observed. After 7 and 10 days of incubation, all cells expressed B220 but were negative for GR-1. These results clearly showed that the majority of LinCkal 
DISCUSSION
The development of advanced methodology to obtain highly enriched stages of early and uncommitted progenitor and stem cells and the identification of cytokines capable of potently stimulating or inhibiting their clonal growth in vitro has increased our understanding of how cytokines might potentially play a role in the growth regulation of primitive hematopoietic progenitor cell^.^^^"' A key and maybe essential phenomenon involved in the regulation of hematopoiesis that has emerged in recent years is the requirement for combined signaling to recruit the most primitive progenitors to proliferate and differentiate.4x.4y Such recruitment might occur through synergistic interactions between multiple soluble cytokines or through an interaction with cytokines and unidentified stromal element^.^^.^^.'' Numerous soluble cytokines have been shown to interact synergistically to potently and selectively stimulate stromaindependent growth and myeloid cell differentiation of primitive hematopoietic progenitor cells such as the Lin-Sca-l+ cells used in this Despite the fact that such highly enriched progenitor cell populations have been shown in vivo to possess both a myeloid and lymphoid cell potentia1,2*,.29 little progress has been made with regard to identifying cytokines that, in vitro, can efficiently and selectively stimulate uncommitted progenitor cells to commit and differentiate to the B-cell lineage. Although studies both in IL-7-and IL-7R-deficient mice clearly show that IL-7 is critical for efficient B-cell generation,"." IL-7 alone is not sufficient to support the earliest stages of B-cell Accordingly, both the B-cell commitment and earliest stages of B-cell differentiation are often referred to as IL-7 as well as ~troma-dependent."-~.'~.'~ Such stroma-dependency could 
(0)
Lin-Sca-l' cells were isolated as described in the Materials and
Methods. For analysis of B220 and GR-1 expression, 2 x 10' cells were seeded in complete IMDM with FL and IL-7 on day 0. After 2, 4, 7, and 10 days of incubation at 37°C and 5% CO, in air, cells were analyzed for B220 and GR-1 expression as described in the Materials and Methods. A minimum of 2,500 cells were analyzed for each sample and expression was defined based on the isotype-matched irrelevant control stained cells as described in 
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VElBY ET AL whereas FL + IL-7 resulted in exclusive B-cell differentiation, SCF + IL-7 stimulated, in agreement with previous cytes. It is interesting that this dramatic difference did not appear to be related to a lack of c-kit expression on the targeted progenitors, because all the responsive progenitors were c-kit'. In addition, all the pro-B cells formed in response to FL + IL-7 expressed c-kit. Lack of function mutants of c-kit (WnV) or SCF (SVS1) indicate that SCFlc-kit is not essential for progenitor B-cell d e~e l o p r n e n t .~~~~~ In fact, in vivo treatment with a blocking c-kit antibody rather enhances B lymphopoiesis while suppressing myelopoiesis/ erythropoiesi~.~~ However, these findings do not rule out a role of SCFlc-kit in regulation of B lymphopoiesis. In fact, combining the flt3 mutation with the c-kit mutation showed a much more severe B-cell (as well as T-cell and myeloid) defect in the double-mutant mice than either of the single rnutant~.~' In addition, we have recently found that SCF, although having little ability to interact with IL-7 alone to stimulate pro-B -cell production from Lin-Sca-1 + progenitor cells, can potently enhance FL + IL-7-induced pro-B-cell formation (Veiby et al, unpublished observation). Thus, FL and SCF might act together to enhance early B-cell growth and differentiation and/or they might act at distinct stages of early B-cell differentiation.
A recent study showed that FL + IL-7 stimulated the growth of B-cell progenitor cells in murine bone marrow. 27 However, in contrast to our findings, SCF + IL-7 was much more potent than FL + IL-7 in stimulating the growth of the investigated B-cell progenitors. Because that study did not specifically investigate the effect on uncommitted progenitor cells, this difference might reflect the use of different target populations.
The IL-7 receptor status of uncommitted bone marrow progenitor cells is not known. The finding that IL-7 had to be added together with FL at the initiation of culture to optimally stimulate pro-B -cell formation suggests that these uncommitted progenitor cells must either constitutively express IL-7R or that FL induces such expression.
Although the present findings combined with the studies in IL-7R and flt3-deficient mice implicate these two receptors and their corresponding ligands in the physiological regulation of B-cell commitment and differentiation, it seems likely that also other receptor-ligand pairs might play a role in this process. Insulin growth factor-l (IGF-l) has, in combination with IL-7, been shown to be capable of stimulating stroma-independent growth of primitive but committed Bcell progenitor cells.57 However, IGF-1 + IL-7 has no ability to induce B-cell commitment and differentiation of Lin-Scal' progenitor cells, and IGF-l does, unlike SCF, not further enhance the FL + IL-7 response (Veiby et al, unpublished observation), suggesting that IGF-1 might not act on the uncommitted progenitor cells. Still, the establishment of the relative role of these as well as other cytokines in the regulation of early B-cell differentiation, in particular in human bone marrow, awaits further studies. Regardless, the present study defines a unique model for studying selective B-cell commitment and development from uncommitted progenitor cells. studies,".'s predominantly the production of mature granulo-
